FIGURE S1.-Sequencing of existing cDNAs reveals multiple egl-9 mRNA isoforms. Boxes represent exons and lines represent introns. MYND and prolyl hydroxylase domains are filled with black. Nineteen cDNAs from the National Institute of Genetics, Mishima, Japan were sequenced in full, and the number cDNAs of each egl-9 isoform in that collection is shown in the righthand column. The cDNA sequences have been submitted to www.wormbase.org.
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prolyl hydroxylase domain FIGURE S1.-Sequencing of existing cDNAs reveals multiple egl-9 mRNA isoforms. Boxes represent exons and lines represent introns. MYND and proly1 hydroxylase domains are filled with black. Nineteen cDNAs from the National Institute of Genetics, Mishima, Japan were sequenced in full, an the number cDNAs of each egl-9 isoform in that collection is shown in the righthand column. The cDNA sequences have been submitted to www.wormbase.org. The HIF-1 (P621G) mutation stabilizes HIF-1 protein. A) Diagrams of minigenes that direct expression of epitope-tagged HIF-1 or HIF-1 (P621G). These transgenes are described as Phif-1::hif-1::tag and Phif-1::hif-1 (P621G)::tag. Boxes represent translated regions.The asterisk indicates sequence encoding proline 621, which was mutated to code for glycine in the P621G construct. B,C) Representative protein blots to analyze the expression of epitope-tagged HIF-1 or HIF-1 (P621G) in transgenic animals. Each strain shown carried the hif-1 (ia04) deletion allele, and HIF-1 function was restored by an integrated copy of one of the hif-1 transgenes. Blots were probed with antibodies that recognize the myc epitope. B) Regulation of epitope-tagged HIF-1 by egl-9 and vhl-1 in transgenic C. elegans. egl-9 (sa307) and vhl-1 (ok161) are strong loss-of-function alleles, and + represents the allele present in wild-type C. elegans (Bristol N2). AHA-1 protein levels are unchanged in these mutant backgrounds. C) The P621G mutation prevented vhl-1-and egl-9-mediated destabilization of HIF-1 protein. Data from at least three independent biological replicates were analyzed to determine whether loss-of-function mutations in vhl-1 or egl-9 resulted in statistically significant differences in HIF-1 or HIF-1 (P621G) protein levels. n.s.: no significant difference; *: p< 0.05; **: p<0.01 elegans. egl-9 (sa307) and vhl-1 (ok161) are strong loss-of-function alleles, and + represents the allele present in wild-type C. elegans (Bristol N2). AHA-1 protein levels are unchanged in these mutant backgrounds. C) The P621G mutation prevented vhl-1 and egl-9-mediated destabilization of HIF-1 protein. Data from at least three independent biological replicates were analyzed to determine whether loss-of-function mutations in vhl-1 or egl-9 resulted in statistically significant differences in HIF-1 or HIF-1 (P621G) protein levels. n.s.: no significant difference; *: p<0.05; **:p<0.01
oxEx166 [Phsp::transposase, oxEx229 iaIs07 iaIs07 ] FIGURE S3.-Diagram describing the MOS1-mediated screen to identify alleles that caused over-expression of Pnhr-57::GFP. The extrachromosomal array that included the MOS1 transposon also carried the Pmyo-2::GFP pharyngeal marker. The array containing Phsp:: transposase included the Punc-122::GFP gene, which labels coelomocytes. Both starting strains carried the Pnhr-57::GFP reporter. F1 eggs that were laid between 18-40 hours after heatshock treatment were collected. Animals over-expressing the HIF-1 reporter were isolated. Inverse PCR and complementation tests with existing egl-9 alleles were used to map the mutation site FIGURE S3.-Diagram describing the MOS1-mediated screen to identify alleles that caused over-expression of Pnhr-57::GFP. The extrachromosomal array that included the MOS1 transposon also carried the Pmyo-2::GFP pharyngeal marker. The array containing Phsp::transposase included the Punc-122::GFP gene, which labels coelomocytes. Both starting strains carried the Pnhr-57::GFP reporter. F1 eggs that were laid between 18-40 hours after heatshock treatment were collected. Animals over-expressing the HIF-1 reporter were isolated. Inverse PCR and complementation tests with existing egl-9 alleles were used to map the mutation site. -Relative expression levels of epitope-tagged EGL-9 protein in transgenic lines. Protein blots were probed with primary antibodies recognizing the GFP tag on the egl-9::GFP and egl-9 (H487A)::GFP transgenes and AHA-1, which was assayed as a loading control. While the expression of EGL-9 protein in iaEx104 is about 3 folds lower than in iaIs38, iaEx101, and iaEx110 transgenes, iaEx104 suppresses hif-1 targets as well (Figure 4 ). This suggests that there may be a threshold level of EGL-9 required for rescue, and that this threshold is achieved by all 4 strains. These data are shown as a representative blot (A.) and a bar chart summarizing three biological replicates (B).
Relative expression iaIs38 iaEx101 iaEx104 iaEx110 FIGURE S4.-Relative expression levels of epitope-tagged EGL-9 protein in transgenic lines. Protein blots were probed with primary antibodies recognizing the GFP tag on the egl-9::GFP and egl-9 (H487A)::GFP transgenes and AHA-1, which was assayed as a loading control. While the expression of EGL-9 protein I iaEx104 is about 3 folds lower than in iaIs38, iaEx101, and iaEx110 transgenes, iaEx104 suppresses hif-1 targets as well (Figure 4 ). This suggests that there may be a threshold level o fEGL-9 required for rescue, and that this threshold is achieved by all 4 strains. These data are shown as a representative blot (A) and a bar chart summarizing three biological replicates (B).
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Supporting Methods
Construction of egl-9 and hif-1 plasmids: To create Pegl-9::egl-9::tag, 1.6 kb of sequence 5' to the egl-9 translational start was amplified and cloned into the pPD95.75 vector (from Andrew Fire) (primers: CGCGCATGCGTGTATGTGTGTGAAAGAG and GCGGTCGACGCAACTTTTTTCTGTCACATTCAG). The remaining coding sequence for egl-9 (exons 3 to end) was amplified from cDNA, using primers 5'GCGGTCGACCACATGACATGAGCAGTGCCCCAAATG and 5'GCGGGATCCGAGATGTAATACTCTGGGTTTGTGGAAGG. The resulting fragment was digested with SalI and BamHI and inserted into the construct containing the egl-9 promoter. Finally, the genomic sequence including the first three egl-9 exons was amplified (primers: 5'GCGGTCGACCACATGACATGAGCAGTGCCCCAAATG and 5'GGATTGGAATCGATGGCTCTGG) and added to the construct using SalI and ClaI restriction sites. Pegl-9::egl-9(H487A)::tag was made by mutating codon His487 to encode alanine.
The Phif-1::hif-1::tag construct contains 5.2 kb of hif-1 5' regulatory sequence, the genomic sequence for the first exon and first intron of hif-1, and cDNA sequence for exons 2 -9. The cDNA sequence is from the predominant hif-1 mRNA isoform (hif-1a).
This construct also includes an epitope tag that consists of one copy of HA and five copies of c-myc (from clone CD3-128, Arabidopsis Biology Resource Center), inserted in frame after the hif-1 coding sequences. The coding sequences are followed by a stop codon and 400 bp of genomic sequence 3' to the hif-1 coding region. To create the Phif-1::hif-1 (P621G)::tag construct, the codon for proline 621 was modified to encode glycine, and the HA sequence was removed from the epitope tag.
Hypoxia treatment and protein blots: To achieve 0.5% oxygen, nitrogen was mixed with room air. To assess the levels of HIF-1 or * These alleles were generated by the C. elegans knock-out consortium. Table S1 DARBY 
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Transgenes used in this study * The promoter is listed first, followed by the coding sequences. ** Integration events were achieved by microparticle bombardment (PRAITIS et al. 2001) and were backcrossed at least four times prior to further characterization. Table S2 Strains to compare the regulation and functions of EGL-9 and EGL-9 (H487A) e Additional strains generated to characterize new and existing egl-9 loss-of-function alleles
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